Attached files
| file | filename |
|---|---|
| 10-Q - 10-Q Q3 2016 FILING - ARIAD PHARMACEUTICALS INC | a2016q310-q.htm |
| EX-31.2 - EXHIBIT 31.2 - ARIAD PHARMACEUTICALS INC | a2016q2exhibit3121.htm |
| EX-31.1 - EXHIBIT 31.1 - ARIAD PHARMACEUTICALS INC | a2016q2exhibit3111.htm |
| EX-10.1 - EXHIBIT 10.1 - ARIAD PHARMACEUTICALS INC | v450376_ex10-1.htm |
EXHIBIT 32.1
CERTIFICATION
PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
(Subsections (a) and (b) of Section 1350, Chapter 63 of Title 18, United States Code)
Pursuant to section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of section 1350, chapter 63 of title 18, United States Code), each of the undersigned officers of ARIAD Pharmaceuticals, Inc., a Delaware corporation (the “Company”), does hereby certify, to such officer’s knowledge, that:
The Quarterly Report on Form 10-Q for the period ended September 30, 2016 (the “Form 10-Q”) of the Company fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, and the information contained in the Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of the Company.
Dated: November 8, 2016 | /s/ Paris Panayiotopoulos | |||
Paris Panayiotopoulos | ||||
President and Chief Executive Officer | ||||
Dated: November 8, 2016 | /s/ Manmeet S. Soni | |||
Manmeet S. Soni | ||||
Executive Vice President, | ||||
Chief Financial Officer and Treasurer | ||||